NDC 60760-743
Gabapentin 600 mg tablet
On the label: St. Mary's Medical Park Pharmacy. It's repackaged: St. Mary's Medical Park Pharmacy rebottles it from ScieGen Pharmaceuticals, Inc.'s NDC 50228-177.
Where the pills inside were made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| ScieGen Pharmaceuticals, INC. | Hauppauge, NY, United States | Makes it and tests it | Problems found, fixed voluntarilyMay 15, 2026 · 15 inspections, 1 with FDA action |
Repackaging site
- St. Mary's Medical Park Pharmacy, Oro Valley, AZ, United States · repackages it and relabels it
Recalls
- Feb 17, 2023 · Class III · Sciegen Pharmaceuticals Inc
Presence of Foreign Tablets/Capsules: Pharmacist reported presence of some Gabapentin tablets 800 mg comingled in Gabapentin 600 mg 500 count bottles.
Lots: Lot # G177092, Exp. 11/24
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Gabapentin: every company that makes it
- Form
- tablet, oral
- Strength
- 600 mg
- Approval
- ANDA ANDA205101
- On the market since
- Jan 28, 2021
- Package NDCs
60760-743-3060760-743-6060760-743-90- Official label
- DailyMed (National Library of Medicine), updated Jun 26, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?